Form Approved: OMB No[removed]Expiration Date: [removed]See PRA Statement below) DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration

First Page		Document Content
Date: 2013-06-03 10:09:54 Pharmaceutical sciences Pharmacology Pharmaceuticals policy MedWatch Pharmaceutical industry Adverse Event Reporting System Medical device Breast implant Prescription medication Medicine Food and Drug Administration Health		Form Approved: OMB No[removed]Expiration Date: [removed]See PRA Statement below) DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Add to Reading List Source URL: www.accessdata.fda.gov Download Document from Source Website File Size: 1,25 MB Share Document on Facebook

	ARTICLE Neonatal Deaths After Hepatitis B Vaccine The Vaccine Adverse Event Reporting System, Manette T. Niu, MD; Marcel E. Salive, MD, MPH; Susan S. Ellenberg, PhD DocID: 1sU4r - View Document
	84521booklet 1_TK-letter-size DocID: 1qPpC - View Document
	QuarterWatch Monitoring FDA MedWatch Reports Why Reports of Serious Adverse Drug Events Continue to Grow October 3, 2012 Data from 2012 Quarter 1 DocID: 1p1ui - View Document
	YELLOW FEVER VACCINE ADVERSE EVENT REPORTING SYSTEM PATIENT IDENTITY KEPT CONFIDENTIAL WEBSITE: www.enivd.de E-MAIL: Phone: ++For internal Use Only Robert Koch Institut, Nordu DocID: 1eA92 - View Document
	YELLOW FEVER VACCINE ADVERSE EVENT REPORTING SYSTEM PATIENT IDENTITY KEPT CONFIDENTIAL WEBSITE: www.enivd.de E-MAIL: FAX: ++For internal Use Only Robert Koch Institut, Nordufer 20 DocID: 1drvk - View Document